New PAREXEL division supports emerging biotech companies

11:26 EST 8 Jan 2019 | Bionity

image description
PAREXEL International Corporation introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively. PAREXEL Biotech builds on the Company’s heritage of clinical, regulatory, commercial and technolog...

Original Article: New PAREXEL division supports emerging biotech companies

More From BioPortfolio on "New PAREXEL division supports emerging biotech companies"